Myrexis, Inc. to Hold Conference Call to Discuss Second Fiscal Quarter 2012 Financial Results

Published: Feb 03, 2012

SALT LAKE CITY, Feb. 3, 2012 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and distinct mechanisms of action, today announced it will hold a conference call on Thursday, February 9, 2012 at 4:30 p.m. ET (1:30 p.m. PT) to discuss financial results for its second fiscal quarter 2012 ended December 31, 2011.

Back to news